Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic therapy for stroke

T Brott1, J Broderick, R Kothari

  • 1University of Cincinnati College of Medicine, Ohio.

Current Opinion in Neurology
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unmet Training Needs of Physiotherapists to Optimise Care for Patients Who Are Homeless.

Journal of allied health·2025
Same author

Optimising Post-Operative Imaging in Hemiarthroplasty.

Irish medical journal·2025
Same author

Acceptability and utility of a broad test battery to evaluate physical functioning and frailty in community-based settings for people experiencing homelessness and addiction-Findings from the LEAP trials.

Physiotherapy·2024
Same author

Publisher Correction: Markedly poor physical functioning status of people experiencing homelessness admitted to an acute hospital setting.

Scientific reports·2021
Same author

Particle composition and morphology over urban environment (New Delhi): Plausible effects on wheat leaves.

Environmental research·2021
Same author

Markedly poor physical functioning status of people experiencing homelessness admitted to an acute hospital setting.

Scientific reports·2021
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Thrombolytic drugs show slight differences in myocardial infarction but modest recanalization in ischemic stroke. Further trials are needed to confirm clinical benefits and understand risks like hemorrhagic stroke.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Thrombolytic drug research is ongoing, with improved dosing regimens.
  • Understanding thrombi physiology and thrombolytic pharmacology is crucial for treatment development.

Purpose of the Study:

  • To review current understanding of thrombolytic therapy for myocardial infarction and ischemic stroke.
  • To assess the efficacy and safety of various thrombolytic agents and administration routes.

Main Methods:

  • Review of recent findings on thrombolytic agents, including tissue plasminogen activator and streptokinase.
  • Analysis of recanalization rates and associated hemorrhagic stroke frequency in different clinical settings.

Main Results:

Related Experiment Videos

  • Thrombolytic agents show minimal differences in myocardial infarction, with slight variations in hemorrhagic stroke rates.
  • Intravenous tissue plasminogen activator for ischemic stroke yields modest recanalization, influenced by clot size.
  • Intra-arterial thrombolytic therapy shows high lysis rates, but clinical benefits require further validation.

    • Conclusions:

    • Clinical benefits of thrombolytic therapy for ischemic stroke await results from ongoing multicenter randomized trials.
    • Further research is essential to establish causal links between thrombolytic therapy and intracranial hemorrhage.
    • Thrombolytic therapy for subarachnoid hemorrhage remains an active area of investigation.